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Science Background
Medication usage records can be used as a relatively non-
intrusive means of monitoring health. This has been 
attempted previously through crew medical records, but these 
records are incomplete from the perspective of a research 
pharmacologist. 
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Science Background
• During the shuttle era, NASA operations did not 
include routine questioning of crewmembers 
about their medication use until after missions 
were complete. 
• The (long!) questionnaire was on paper.
• Asking crewmembers to recall medication use 
from weeks before questioning made getting 
complete and accurate information virtually 
impossible.
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Science Background
This study will document medication usage of crewmembers 
before and during their missions. It will capture previously 
unrecorded data regarding medication use during spaceflight, 
including side effect qualities, frequencies and severities. The 
research-oriented data will be collected for research purposes, 
separate from medical records.
Dose Tracker employs an iOS application (app) for fast & 
easy collection of medication usage data from crewmember 
participants during their missions.  
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Hypothesis
Until now, there has been no specific research conducted on 
medication usage during ISS missions, as opposed to shorter 
shuttle missions.  The intent of Dose Tracker is to analyze the 
effects of taking various medications on long duration space 
missions to LEO vs. on Earth. We expect to see certain 
operationally-driven instances of medication use (for space 
adaptation syndrome, for instance). But the study hypothesis is 
that: 
A crewmember’s medication usage during an ISS mission will 
not differ greatly from their typical usage on Earth. 
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Investigational Goal: 
Can medication usage data provide evidence of spaceflight-alterations in PK or PD? 
Pharmacokinetics
How the body handles 
medications: absorption, 
distribution, metabolism, 
excretion
Pharmacodynamics
How the medication interacts 
with target molecules and 
biochemical pathways
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Specific Aims:
1. To gather enough data to indicate if there might be any 
pharmacokinetic or pharmacodynamic changes during 
spaceflight.
2. To understand if there are any unusual side effects and/or 
adverse events from medication usage in space.
3. To acquire sufficient in-flight medication usage data to power 
future studies and better protect the personal health of 
crewmembers.
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Measurement Approach
Research-oriented medication usage data will be self-
reported by subjects for the entirety of their ISS missions. 
Ground data for each subject will be collected for a period 
of time that roughly matches the duration of their ISS 
mission, during a convenient pre-flight time period.
An iOS app was develop to enable crewmember subjects 
to record their own medication usage information as 
simply and efficiently as possible. 
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Reason for use of the ISS
This study requires use of the ISS because no 
ground analog has been validated as appropriate for 
pharmacology experiments. 
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Test/Session Descriptions
What is the Dose Tracker App?
Dose Tracker is an iPad application that will permit 
crewmembers to “track” all medication usage –
prescription medications, over the counter 
medications (e.g., Advil, Tums), vitamins, minerals, 
supplements, etc.  
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Test/Session Descriptions
The Dose Tracker Application will be used to permit fast and efficient 
collection of data regarding crewmembers’ medication use on a near real-
time basis, eliminating the current problems associated with recall over 
periods of weeks.  Specific questions regarding medication use (somewhat 
different from the questions that physicians ask regarding patient health) 
will be asked of each participating crewmember. 
The data collection process will be streamlined by using a flexibly 
programmed computerized survey application that leverages the limited 
medication choices aboard, the doses available, typical dosing frequency, 
and side effects associated with each medication to provide an 
individualized short questionnaire for each medication use by the 
crewmember. 
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Test/Session Descriptions
Its simplicity and design make Dose Tracker very user-friendly.  
• Once you log in, a question will 
appear for that week asking you 
if you have taken any 
medications for that week.  
• If you haven’t, choose “no” and 
the questionnaire will end.  
• If “yes,” simply proceed to fill out 
the questions that will follow.
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Expected results
Previous studies have indicated that crewmembers' use of 
medications on short-duration spaceflight missions is roughly similar 
to what is seen for healthy individuals in adult ambulatory medicine. 
We expect this study to show if the same is true for long-duration 
missions. 
This information will be operationally useful for mission planning 
(what medications to provide, and in what quantities). 
This study may also serve to highlight topic areas that require 
attention, by possibly indicating medications that are not as effective 
as expected, or those will unusual side effects during missions. 
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Earth benefits
The Dose Tracker iOS application could be used 
in other, non-spaceflight scenarios to collect 
medication usage information. 
Knowledge gained from this study could provide 
additional insight into medication mechanisms of 
action, by highlighting possible radiation or 
gravitation influences on either PK or PD. 
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Back up slides
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Experiment Design Overview
Preflight Inflight Postflight
Dose Tracker Familiarization 
Session
Dose Tracker sessions once per 
week in-flight
Dose Tracker session once during
R+1 week
Dose Tracker Personalization 
(optional, pending crew preference) 
Historical Photo
Dose Tracker sessions once per 
week for duration equivalent to on-
orbit mission (ground phase)
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Test/Session Descriptions
The success of this project will depend largely on the 
information that is entered.  The more complete, honest 
and thorough your entries are, the more accurate our 
assessment can be.
As a reminder, only our research team will see these 
results; Dose  Tracker data will not be shared with 
Medical Operations. All your data are strictly 
confidential; nothing attributable to an individual will 
be published.
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Test/Session Descriptions
Pre-flight, crewmembers will be asked to complete the Dose Tracker App 
on the ground at least once per week for a duration equal to their in-
flight mission (approximately 24 sessions).  This will begin between L-12 
and L-9 months from launch. 
The crewmember will participate in a familiarization session pre-flight 
at which time they will learn how to enter data successfully into the Dose 
Tracker App on the iPad.  
The application may be personalized with the crewmember’s specific 
medication information, if the crewmember elects this option. 
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Test/Session Descriptions
Personalization of Dose Tracker
1) Default –list of medications already loaded onto the application 
(IMAK).
2) Personal Meds –can include a list of personal medications (requires 
disclosure of personal pack contents).
3) Chronic Meds–can pre-program entries for scheduled medication uses 
(pre-populated automatic pop-up window that only requires a single click 
if you took your medication as scheduled)
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Test Risks/Discomforts Mitigation
Dose Tracker Session (if 
accidental release of data)
Loss of confidentiality of PHI. 
Risk of professional or personal 
embarrassment.
Data will be coded and password 
protected by the investigators and 
are stored encrypted. Personal 
iPads are permitted; the software 
will have the security built into it.
Risks & Discomforts
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Test Constraints
Dose Tracker Session Will be performed every 6-8 days (once per week)
Test Constraints
Entries may be made more frequently than once per week. If 
it’s more convenient for you to enter a medication use at the 
time you take a dose, please do. If it’s more convenient for you 
to enter medication uses on a daily basis, please do. 
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Experiment Training Schedule
Session Title Session 
Type
Timeframe Duration Location Required 
for 
Operators
Required 
for 
Subjects
NO TRAINING REQUIRED
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Summary
Preflight Inflight Postflight
Dose Tracker Familiarization 
Session (no more than 30 days 
prior to start of Dose Tracker 
Ground Phase) -30 minutes for one 
session
Dose Tracker Personalization 
(optional, pending crew 
preference) -5 minutes for one 
session
Dose Tracker (every 6-8 
days starting on FD7 (+1) -
approximately 24 sessions 
per mission, 15 minutes 
per session)
Dose Tracker (R+1 week, 
10 minutes per session)
Dose Tracker Ground Phase (First 
entry scheduled between L-12 and 
L-9 months from launch, then one 
session every 6-8 days for duration 
equivalent to on-orbit mission -
approximately 24 sessions, 10 
minutes per session)
Historical photo (10
minutes of reserve time 
once per mission)
Total Time: 
275 minutes (4.6 hours)
Total Time: 
360 minutes (6 hours)
Total Time:
10 minutes
